Redox signaling in angiogenesis: Role of NADPH oxidase

Cardiovascular Research

Volumn 71, Issue 2, 2006, Pages 226-235

  Ushio Fukai, Masuko ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; NADPH oxidase; Reactive oxygen species; Redox signaling

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROTEIN; PROTEIN P22; PROTEIN P47; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; CARDIOVASCULAR DISEASE; CELL MIGRATION; CHEMOTAXIS; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE CONTROL; GENE EXPRESSION; HEART DISEASE; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; UPREGULATION;

ANGIOTENSIN II; ANIMALS; ATHEROSCLEROSIS; ENDOTHELIAL CELLS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HUMANS; NADPH OXIDASE; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

EID: 33745217132     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.04.015     Document Type: Review

References (121)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1 (1995) 27-31
2. Matsumoto T., and Claesson-Welsh L. VEGF receptor signal transduction. Sci STKE 2001 (2001) RE21
3. Griendling K.K., Sorescu D., and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86 (2000) 494-501
4. Stone J.R., and Collins T. The role of hydrogen peroxide in endothelial proliferative responses. Endothelium 9 (2002) 231-238
5. Ushio-Fukai M., Tang Y., Fukai T., Dikalov S., Ma Y., Fujimoto M., et al. Novel role of gp91phox-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 91 (2002) 1160-1167
6. Luczak K., Balcerczyk A., Soszynski M., and Bartosz G. Low concentration of oxidant and nitric oxide donors stimulate proliferation of human endothelial cells in vitro. Cell Biol Int 28 (2004) 483-486
7. Maulik N. Redox regulation of vascular angiogenesis. Antioxid Redox Signal 4 (2002) 783-784
8. Tojo T., Ushio-Fukai M., Yamaoka-Tojo M., Ikeda S., Patrushev N.A., and Alexander R.W. Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation 111 (2005) 2347-2355
9. Chen W., Gabel S., Steenbergen C., and Murphy E. A redox-based mechanism for cardioprotection induced by ischemic preconditioning in perfused rat heart. Circ Res 77 (1995) 424-429
10. Skyschally A., Schulz R., Gres P., Korth H.G., and Heusch G. Attenuation of ischemic preconditioning in pigs by scavenging of free oxyradicals with ascorbic acid. Am J Physiol Heart Circ Physiol 284 (2003) H698-03
11. Tanaka K., Weihrauch D., Kehl F., Ludwig L.M., LaDisa Jr. J.F., Kersten J.R., et al. Mechanism of preconditioning by isoflurane in rabbits: a direct role for reactive oxygen species. Anesthesiology 97 (2002) 1485-1490
12. Lassegue B., and Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285 (2003) R277-R297
13. Ushio-Fukai M., and Alexander R.W. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem 264 (2004) 85-97
14. Harfouche R., Malak N.A., Brandes R.P., Karsan A., Irani K., and Hussain S.N. Roles of reactive oxygen species in angiopoietin-1/tie-2 receptor signaling. FASEB J 19 (2005) 1728-1730
15. Yamaoka-Tojo M., Ushio-Fukai M., Hilenski L., Dikalov S.I., Chen Y.E., Tojo T., et al. IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species-dependent endothelial migration and proliferation. Circ Res 95 (2004) 276-283
16. Ikeda S., Ushio-Fukai M., Zuo L., Tojo T., and Alexander R.W. Novel role of ARF6 in vascular endothelial growth factor signaling and angiogenesis. Circ Res 96 (2005) 467-475
17. Al-Shabrawey M., Bartoli M., El-Remessy A.B., Platt D.H., Matragoon S., Behzadian M.A., et al. Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy. Am J Pathol 167 (2005) 599-607
18. Ruef J., Hu Z.Y., Yin L.Y., Wu Y., Hanson S.R., Kelly A.B., et al. Induction of vascular endothelial growth factor in balloon-injured baboon arteries. Circ Res 81 (1997) 24-33
19. 2 in rat heart endothelial cells. Free Radic Biol Med 25 (1998) 891-897
20. Yasuda M., Ohzeki Y., Shimizu S., Naito S., Ohtsuru A., Yamamoto T., et al. Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sci 64 (1999) 249-258
21. Vepa S., Scribner W.M., Parinandi N.L., English D., Garcia J.G., and Natarajan V. Hydrogen peroxide stimulates tyrosine phosphorylation of focal adhesion kinase in vascular endothelial cells. Am J Physiol 277 (1999) L150-L158
22. Shono T., Ono M., Izumi H., Jimi S.I., Matsushima K., Okamoto T., et al. Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol 16 (1996) 4231-4239
23. Lelkes P.I., Hahn K.L., Sukovich D.A., Karmiol S., and Schmidt D.H. On the possible role of reactive oxygen species in angiogenesis. Adv Exp Med Biol 454 (1998) 295-310
24. Yasuda M., Shimizu S., Tokuyama S., Watanabe T., Kiuchi Y., and Yamamoto T. A novel effect of polymorphonuclear leukocytes in the facilitation of angiogenesis. Life Sci 66 (2000) 2113-2121
25. Qian Y., Luo J., Leonard S.S., Harris G.K., Millecchia L., Flynn D.C., et al. Hydrogen peroxide formation and actin filament reorganization by Cdc42 are essential for ethanol-induced in vitro angiogenesis. J Biol Chem 278 (2003) 16189-16197
26. Yamagishi S., Amano S., Inagaki Y., Okamoto T., Takeuchi M., and Inoue H. Pigment epithelium-derived factor inhibits leptin-induced angiogenesis by suppressing vascular endothelial growth factor gene expression through anti-oxidative properties. Microvasc Res 65 (2003) 186-190
27. Tang F.Y., and Meydani M. Green tea catechins and vitamin E inhibit angiogenesis of human microvascular endothelial cells through suppression of IL-8 production. Nutr Cancer 41 (2001) 119-125
28. Dawson D.W., Volpert O.V., Gillis P., Crawford S.E., Xu H., Benedict W., et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285 (1999) 245-248
29. Lambeth J.D., Cheng G., Arnold R., and Edens W.A. Novel homologs of gp91phox. Trends Biochem Sci 25 (2000) 459-461
30. Babior B.M. The NADPH oxidase of endothelial cells. IUBMB Life 50 (2000) 267-269
31. Li J.M., and Shah A.M. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 287 (2004) R1014-R1030
32. Gorlach A., Brandes R.P., Nguyen K., Amidi M., Dehghani F., and Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87 (2000) 26-32
33. Li J.-M., and Shah A.M. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem 277 (2002) 19952-19960
34. Frey R.S., Rahman A., Kefer J.C., Minshall R.D., and Malik A.B. PKCzeta regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells. Circ Res 90 (2002) 1012-1019
35. Furst R., Brueckl C., Kuebler W.M., Zahler S., Krotz F., Gorlach A., et al. Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activation. Circ Res 96 (2005) 43-53
36. Ikeda S., Yamaoka-Tojo M., Hilenski L., Patrushev N.A., Anwar G.M., Quinn M.T., et al. IQGAP1 regulates reactive oxygen species-dependent endothelial cell migration through interacting with Nox2. Arterioscler Thromb Vasc Biol 25 (2005) 2295-2300
37. Djordjevic T., Pogrebniak A., BelAiba R.S., Bonello S., Wotzlaw C., Acker H., et al. The expression of the NADPH oxidase subunit p22phox is regulated by a redox-sensitive pathway in endothelial cells. Free Radic Biol Med 38 (2005) 616-630
38. Yamagishi S., Nakamura K., Ueda S., Kato S., and Imaizumi T. Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF. Cell Tissue Res 320 (2005) 437-445
39. van Wetering S., van Buul J.D., Quik S., Mul F.P., Anthony E.C., ten Klooster J.P., et al. Reactive oxygen species mediate Rac-induced loss of cell-cell adhesion in primary human endothelial cells. J Cell Sci 115 (2002) 1837-1846
40. Moldovan L., Irani K., Moldovan N.I., Finkel T., and Goldschmidt-Clermont P.J. The actin cytoskeleton reorganization induced by Rac1 requires the production of superoxide. Antioxid Redox Signal 1 (1999) 29-43
41. Kraynov V.S., Chamberlain C., Bokoch G.M., Schwartz M.A., Slabaugh S., and Hahn K.M. Localized Rac activation dynamics visualized in living cells. Science 290 (2000) 333-337
42. Moldovan L., Moldovan N.I., Sohn R.H., Parikh S.A., and Goldschmidt-Clermont P.J. Redox changes of cultured endothelial cells and actin dynamics. Circ Res 86 (2000) 549-557
43. Li J.M., Mullen A.M., Yun S., Wientjes F., Brouns G.Y., Thrasher A.J., et al. Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha. Circ Res 90 (2002) 143-150
44. Hwang J., Saha A., Boo Y.C., Sorescu G.P., McNally J.S., Holland S.M., et al. Oscillatory shear stress stimulates endothelial production of O2- from p47phox-dependent NAD(P)H oxidases, leading to monocyte adhesion. J Biol Chem 278 (2003) 47291-47298
45. Li J.M., and Shah A.M. Mechanism of endothelial cell NADPH oxidase activation by angiotensin: II. Role of the p47phox subunit. J Biol Chem 278 (2003) 12094-12100
46. Gu Y., Xu Y.C., Wu R.F., Souza R.F., Nwariaku F.E., and Terada L.S. TNFalpha activates c-Jun amino terminal kinase through p47(phox). Exp Cell Res 272 (2002) 62-74
47. Wu R.F., Gu Y., Xu Y.C., Nwariaku F.E., and Terada L.S. Vascular endothelial growth factor causes translocation of p47phox to membrane ruffles through WAVE1. J Biol Chem 278 (2003) 36830-36840
48. Wu R.F., Xu Y.C., Ma Z., Nwariaku F.E., Sarosi Jr. G.A., and Terada L.S. Subcellular targeting of oxidants during endothelial cell migration. J Cell Biol 171 (2005) 893-904
49. Sorescu G.P., Song H., Tressel S.L., Hwang J., Dikalov S., Smith D.A., et al. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circ Res 95 (2004) 773-779
50. Kobayashi S., Nojima Y., Shibuya M., and Maru Y. Nox1 regulates apoptosis and potentially stimulates branching morphogenesis in sinusoidal endothelial cells. Exp Cell Res 300 (2004) 455-462
51. Ago T., Kitazono T., Ooboshi H., Iyama T., Han Y.H., Takada J., et al. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109 (2004) 227-233
52. Kuroda J., Nakagawa K., Yamasaki T., Nakamura K., Takeya R., Kuribayashi F., et al. The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells 10 (2005) 1139-1151
53. Geiszt M., Kopp J.B., Varnai P., and Leto T.L. Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A 97 (2000) 8010-8014
54. Abid M.R., Tsai J.C., Spokes K.C., Deshpande S.S., Irani K., and Aird W.C. Vascular endothelial growth factor induces manganese-superoxide dismutase expression in endothelial cells by a Rac1-regulated NADPH oxidase-dependent mechanism. FASEB J 15 (2001) 2548-2550
55. Colavitti R., Pani G., Bedogni B., Anzevino R., Borrello S., Waltenberger J., et al. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem 277 (2002) 3101-3108
56. Lin M.T., Yen M.L., Lin C.Y., and Kuo M.L. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Mol Pharmacol 64 (2003) 1029-1036
57. Rhee S.G., Bae Y.S., Lee S.R., and Kwon J. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE 2000 (2000) PE1
58. Chiarugi P., and Cirri P. Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. Trends Biochem Sci 28 (2003) 509-514
59. Kwon J., Lee S.R., Yang K.S., Ahn Y., Kim Y.J., Stadtman E.R., et al. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc Natl Acad Sci U S A 101 (2004) 16419-16424
60. Kroll J., and Waltenberger J. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J Biol Chem 272 (1997) 32521-32527
61. Guo D.Q., Wu L.W., Dunbar J.D., Ozes O.N., Mayo L.D., Kessler K.M., et al. Tumor necrosis factor employs a protein-tyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factor-induced endothelial cell proliferation. J Biol Chem 275 (2000) 11216-11221
62. Huang L., Sankar S., Lin C., Kontos C.D., Schroff A.D., Cha E.H., et al. HCPTPA, a protein tyrosine phosphatase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity. J Biol Chem 274 (1999) 38183-38188
63. Grazia Lampugnani M., Zanetti A., Corada M., Takahashi T., Balconi G., Breviario F., et al. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J Cell Biol 161 (2003) 793-804
64. Soeda S., Shimada T., Koyanagi S., Yokomatsu T., Murano T., Shibuya S., et al. An attempt to promote neo-vascularization by employing a newly synthesized inhibitor of protein tyrosine phosphatase. FEBS Lett 524 (2002) 54-58
65. Huang L., Turck C.W., Rao P., and Peters K.G. GRB2 and SH-PTP2: potentially important endothelial signaling molecules downstream of the TEK/TIE2 receptor tyrosine kinase. Oncogene 11 (1995) 2097-2103
66. Murohara T., and Asahara T. Nitric oxide and angiogenesis in cardiovascular disease. Antioxid Redox Signal 4 (2002) 825-831
67. Bayraktutan U. Nitric oxide synthase and NAD(P)H oxidase modulate coronary endothelial cell growth. J Mol Cell Cardiol 36 (2004) 277-286
68. Cai H., Griendling K.K., and Harrison D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 24 (2003) 471-478
69. Polytarchou C., and Papadimitriou E. Antioxidants inhibit human endothelial cell functions through down-regulation of endothelial nitric oxide synthase activity. Eur J Pharmacol 510 (2005) 31-38
70. Lauer N., Suvorava T., Ruther U., Jacob R., Meyer W., Harrison D.G., et al. Critical involvement of hydrogen peroxide in exercise-induced up-regulation of endothelial NO synthase. Cardiovasc Res 65 (2005) 254-262
71. Tamarat R., Silvestre J.S., Kubis N., Benessiano J., Duriez M., deGasparo M., et al. Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb. Hypertension 39 (2002) 830-835
72. 2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 28 (2000) 91-101
73. Ellis E.A., Grant M.B., Murray F.T., Wachowski M.B., Guberski D.L., Kubilis P.S., et al. Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 24 (1998) 111-120
74. Caldwell R.B., Bartoli M., Behzadian M.A., El-Remessy A.E., Al-Shabrawey M., Platt D.H., et al. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr Drug Targets 6 (2005) 511-524
75. Kuroki M., Voest E.E., Amano S., Beerepoot L.V., Takashima S., Tolentino M., et al. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest 98 (1996) 1667-1675
76. Lakshminarayanan V., Lewallen M., Frangogiannis N.G., Evans A.J., Wedin K.E., Michael L.H., et al. Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia. Am J Pathol 159 (2001) 1301-1311
77. Gu W., Weihrauch D., Tanaka K., Tessmer J.P., Pagel P.S., Kersten J.R., et al. Reactive oxygen species are critical mediators of coronary collateral development in a canine model. Am J Physiol Heart Circ Physiol 285 (2003) H1582-H1589
78. Roy S., Khanna S., Nallu K., Hunt T.K., and Sen C.K. Dermal wound healing is subject to redox control. Mol Ther 13 (2006) 211-220
79. Yoshida A., Yoshida S., Ishibashi T., Kuwano M., and Inomata H. Suppression of retinal neovascularization by the NF-kappaB inhibitor pyrrolidine dithiocarbamate in mice. Invest Ophthalmol Vis Sci 40 (1999) 1624-1629
80. Cao Y., and Cao R. Angiogenesis inhibited by drinking tea [letter]. Nature 398 (1999) 381
81. Dona M., Dell'Aica I., Calabrese F., Benelli R., Morini M., Albini A., et al. Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J Immunol 170 (2003) 4335-4341
82. Brakenhielm E., Cao R., and Cao Y. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J 15 (2001) 1798-1800
83. Oak M.H., El Bedoui J., and Schini-Kerth V.B. Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutr Biochem 16 (2005) 1-8
84. Polytarchou C., and Papadimitriou E. Antioxidants inhibit angiogenesis in vivo through down-regulation of nitric oxide synthase expression and activity. Free Radic Res 38 (2004) 501-508
85. Moulton K.S., Heller E., Konerding M.A., Flynn E., Palinski W., and Folkman J. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 99 (1999) 1726-1732
86. Nespereira B., Perez-Ilzarbe M., Fernandez P., Fuentes A.M., Paramo J.A., and Rodriguez J.A. Vitamins C and E downregulate vascular VEGF and VEGFR-2 expression in apolipoprotein-E-deficient mice. Atherosclerosis 171 (2003) 67-73
87. Monte M., Davel L.E., and Sacerdote de Lustig E. Hydrogen peroxide is involved in lymphocyte activation mechanisms to induce angiogenesis. Eur J Cancer 33 (1997) 676-682
88. Cai T., Fassina G., Morini M., Aluigi M.G., Masiello L., Fontanini G., et al. N-Acetylcysteine inhibits endothelial cell invasion and angiogenesis. Lab Invest 79 (1999) 1151-1159
89. Abe R., Shimizu T., Yamagishi S., Shibaki A., Amano S., Inagaki Y., et al. Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo. Am J Pathol 164 (2004) 1225-1232
90. Vallet P., Charnay Y., Steger K., Ogier-Denis E., Kovari E., Herrmann F., et al. Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia. Neuroscience 132 (2005) 233-238
91. Khatri J.J., Johnson C., Magid R., Lessner S.M., Laude K.M., Dikalov S.I., et al. Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation 109 (2004) 520-525
92. Laufs U., Kilter H., Konkol C., Wassmann S., Bohm M., and Nickenig G. Impact of HMG CoA reductase inhibition on small GTPases in the heart. Cardiovasc Res 53 (2002) 911-920
93. Weis M., Heeschen C., Glassford A.J., and Cooke J.P. Statins have biphasic effects on angiogenesis. Circulation 105 (2002) 739-775
94. Arbiser J.L., Petros J., Klafter R., Govindajaran B., McLaughlin E.R., Brown L.F., et al. Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci U S A 99 (2002) 715-720
95. Bell L., and Madri J.A. Influence of the angiotensin system on endothelial and smooth muscle cell migration. Am J Pathol 137 (1990) 7-12
96. Otani A., Takagi H., Suzuma K., and Honda Y. Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells. Circ Res 82 (1998) 619-628
97. Ushio-Fukai M., Griendling K.K., Becker P.L., Hilenski L., Halleran S., and Alexander R.W. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21 (2001) 489-495
98. Fujiyama S., Matsubara H., Nozawa Y., Maruyama K., Mori Y., Tsutsumi Y., et al. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. Circ Res 88 (2001) 22-29
99. Munzenmaier D.H., and Greene A.S. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension 27 (1996) 760-765
100. Sasaki K., Murohara T., Ikeda H., Sugaya T., Shimada T., Shintani S., et al. Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J Clin Invest 109 (2002) 603-611
101. Emanueli C., Salis M.B., Stacca T., Pinna A., Gaspa L., and Madeddu P. Angiotensin AT(1) receptor signalling modulates reparative angiogenesis induced by limb ischaemia. Br J Pharmacol 135 (2002) 87-92
102. Walsh D.A., Hu D.E., Wharton J., Catravas J.D., Blake D.R., and Fan T.P. Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma. Br J Pharmacol 120 (1997) 1302-1311
103. Tamarat R., Silvestre J.S., Durie M., and Levy B.I. Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab Invest 82 (2002) 747-756
104. Amaral S.L., Linderman J.R., Morse M.M., and Greene A.S. Angiogenesis induced by electrical stimulation is mediated by angiotensin II and VEGF. Microcirculation 8 (2001) 57-67
105. Muramatsu M., Katada J., Hayashi I., and Majima M. Chymase as a proangiogenic factor. A possible involvement of chymase-angiotensin-dependent pathway in the hamster sponge angiogenesis model. J Biol Chem 275 (2000) 5545-5552
106. Fujita M., Hayashi I., Yamashina S., Itoman M., and Majima M. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun 294 (2002) 441-447
107. Yoshiji H., Kuriyama S., Kawata M., Yoshii J., Ikenaka Y., Noguchi R., et al. The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor. Clin Cancer Res 7 (2001) 1073-1078
108. Chintalgattu V., Nair D.M., and Katwa L.C. Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR. J Mol Cell Cardiol 35 (2003) 277-286
109. Shimizu T., Okamoto H., Chiba S., Matsui Y., Sugawara T., Akino M., et al. VEGF-mediated angiogenesis is impaired by angiotensin type 1 receptor blockade in cardiomyopathic hamster hearts. Cardiovasc Res 58 (2003) 203-212
110. Jesmin S., Hattori Y., Sakuma I., Mowa C.N., and Kitabatake A. Role of ANG II in coronary capillary angiogenesis at the insulin-resistant stage of a NIDDM rat model. Am J Physiol Heart Circ Physiol 283 (2002) H1387-H1397
111. Wheeler M.D., Smutney O.M., and Samulski R.J. Secretion of extracellular superoxide dismutase from muscle transduced with recombinant adenovirus inhibits the growth of B16 melanomas in mice. Mol Cancer Res 1 (2003) 871-881
112. Marikovsky M., Nevo N., Vadai E., and Harris-Cerruti C. Cu/Zn superoxide dismutase plays a role in angiogenesis. Int J Cancer 97 (2002) 34-41
113. Grzenkowicz-Wydra J., Cisowski J., Nakonieczna J., Zarebski A., Udilova N., Nohl H., et al. Gene transfer of CuZn superoxide dismutase enhances the synthesis of vascular endothelial growth factor. Mol Cell Biochem 264 (2004) 169-181
114. 2 regulates the angiogenic phenotype via PTEN oxidation. J Biol Chem 280 (2005) 16916-16924
115. BelAiba R.S., Djordjevic T., Bonello S., Flugel D., Hess J., Kietzmann T., et al. Redox-sensitive regulation of the HIF pathway under non-hypoxic conditions in pulmonary artery smooth muscle cells. Biol Chem 385 (2004) 249-257
116. Kietzmann T., and Gorlach A. Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin Cell Dev Biol 16 (2005) 474-486
117. Dery M.A., Michaud M.D., and Richard D.E. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 37 (2005) 535-540
118. Gorlach A., Berchner-Pfannschmidt U., Wotzlaw C., Cool R.H., Fandrey J., Acker H., et al. Reactive oxygen species modulate HIF-1 mediated PAI-1 expression: involvement of the GTPase Rac1. Thromb Haemost 89 (2003) 926-935
119. Oka H., Kugiyama K., Doi H., Matsumura T., Shibata H., Miles L.A., et al. Lysophosphatidylcholine induces urokinase-type plasminogen activator and its receptor in human macrophages partly through redox-sensitive pathway. Arterioscler Thromb Vasc Biol 20 (2000) 244-250
120. Inoue N., Takeshita S., Gao D., Ishida T., Kawashima S., Akita H., et al. Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells. Atherosclerosis 155 (2001) 45-52
121. Wary K.K., Thakker G.D., Humtsoe J.O., and Yang J. Analysis of VEGF-responsive genes involved in the activation of endothelial cells. Mol Cancer 2 (2003) 25